Prescription medication · NSAID (Ophthalmic)
ketorolac ophthalmic
Also sold as Acular. Acular LS eye drops treat pain, burning, and stinging in the eye.
Data updated 2026-05-15
- $53.10
- Brand price (NADAC)
ketorolac ophthalmic (Acular) is a prescription NSAID (Ophthalmic). Acular LS eye drops treat pain, burning, and stinging in the eye.
Acular LS eye drops help reduce pain, burning, and stinging in your eyes after surgery to correct your vision. It is a nonsteroidal anti-inflammatory drug (NSAID).
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Brand Price
$53.10/unit
Generic Available
No
Pricing data from NADAC (CMS), effective November 20, 2024. Compare all drug costs →
What it does
Acular LS eye drops treat pain, burning, and stinging in the eye.
Common side effects
Eye redness, Corneal infiltrates, Headache
Key warnings
Acular LS may slow or delay healing.
The sections below are summarized in plain English from ketorolac ophthalmic's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Acular LS is an NSAID that reduces substances in the body that cause pain and inflammation. It blocks the production of prostaglandins. Prostaglandins cause pain and swelling.
Serious Warnings
Acular LS may slow or delay healing. Be careful if you are sensitive to aspirin or other NSAIDs. Acular LS may increase bleeding time. Using NSAIDs like Acular LS may cause cornea problems. If you have issues with the cornea, stop using the drops and see your doctor.
Common Questions
Can I use Acular LS for any type of eye pain?
How long can I use Acular LS after opening the bottle?
What should I do if the tip of the bottle touches my eye?
Can I use Acular LS with my contact lenses?
What if my pain gets worse while using Acular LS?
Can I drive while using Acular LS?
Is it okay to use Acular LS long-term?
What should I do if I experience eye swelling or redness?
Can children use Acular LS?
What if I am allergic to other NSAIDs like ibuprofen?
What are the common side effects of ketorolac ophthalmic?
What drug class is ketorolac ophthalmic?
What pregnancy or breastfeeding source fields are listed for ketorolac ophthalmic?
Related Medications in NSAID (Ophthalmic)
Other drugs grouped near ketorolac ophthalmic - same-class peers and common alternatives.
aflibercept
Eylea
AHZANTIVE is a medicine used to treat certain eye problems.
Compare with ketorolac ophthalmic →
artificial tears
Refresh, Systane
Artificial tears are eye drops that lubricate your eyes.
Compare with ketorolac ophthalmic →
bevacizumab (ophthalmic)
Avastin
Avastin is a medicine that blocks a protein called vascular endothelial growth factor (VEGF).
Compare with ketorolac ophthalmic →
bimatoprost
Lumigan
Bimatoprost eye drops help lower pressure in the eye.
Compare with ketorolac ophthalmic →
brimonidine ophthalmic
Alphagan P
Alphagan P eye drops help lower pressure in the eye.
Compare with ketorolac ophthalmic →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on ketorolac ophthalmic
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for ketorolac ophthalmic
The FDA label for ketorolac ophthalmic (sold under brand names such as Acular) classifies it as a prescription-only medication in the NSAID (Ophthalmic) class. Acular LS eye drops treat pain, burning, and stinging in the eye. Official labeling lists 5 commonly reported side effects, including Eye redness, Corneal infiltrates, Headache.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. Voluntary reports accumulate over the lifetime of a drug and reflect wide-ranging clinical use. Interaction data is drawn directly from FDA-approved prescribing information. NADAC pricing from CMS.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: June 21, 2024
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages